Imaging of adrenal masses with emphasis on adrenocortical tumors

Theranostics

Volumn 2, Issue 5, 2012, Pages 516-522

  Sundin, Anders ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adenoma; Adrenal; Adrenocortical cancer; Computed tomography; Fdg; Incidentaloma; Magnetic resonance imaging; Metomidate; Positron emission tomography

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; 6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; ALDOSTERONE SYNTHASE; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; KETOCONAZOLE; METOMIDATE C 11; METYRAPONE; RADIOPHARMACEUTICAL AGENT; STEROID 11BETA MONOOXYGENASE; STREPTOZOCIN; UNCLASSIFIED DRUG;

ADRENAL BIOPSY; ADRENAL CORTEX; ADRENAL CORTEX ADENOMA; ADRENAL CORTEX TUMOR; ADRENAL METASTASIS; AUTORADIOGRAPHY; BENIGN TUMOR; CANCER DIAGNOSIS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; ENZYME BINDING; FALSE POSITIVE RESULT; FOLLOW UP; FROZEN SECTION; HISTOPATHOLOGY; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; INCIDENTALOMA; META ANALYSIS (TOPIC); METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY HYPERALDOSTERONISM; RADIATION DOSE; RADIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW (TOPIC); TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

EID: 84864539043     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3613     Document Type: Review

References (37)

1. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol. 1998; 171:201-4.
2. Ozcan Kara P, Kara T, Kara Gedik G, et al. The role of fluorodeox-yglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions. Nucl Med Commun. 2011; 32:106-12.
3. Korobkin M, Brodeur FJ, Francis IR, et al. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. Am J Roentgenol 1998; 170:747-752.
4. Caoili EM, Korobkin M, Francis IR, et al. Delayed enhanced CT of lipid-poor adrenal adenomas. Am J Roentgenol 2000;175:1411-1415.
5. Caoili EM, Korobkin M, Francis IR, et al. Adrenal masses: charac-terization with combined unenhanced and delayed enhanced CT. Radiology 2002; 222:629-633.
6. Kebapci M, Kaya T, Gurbuz E, et al. Differentiation of adrenal adenomas (lipid rich and lipid poor) from nonadenomas by use of washout characteristics on delayed enhanced CT. Abdom Imaging 2003; 28:709-715
7. Korobkin M, Lombardi TJ, Aisen AM, et al. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology. 1995; 197:411-8.
8. Korobkin M, Giordano TJ, Brodeur FJ, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Ra-diology. 1996; 200:743-7.
9. Volpe C, Enberg U, Sjögren A, et al. The role of adrenal scintigraphy in the preoperative management of primary aldosteronism. Scand J Surg. 2008; 97:248-53.
10. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1995; 194:131-4.
11. Maurea S, Mainolfi C, Bazzicalupo L, et al. Imaging of adrenal tumors using FDG PET: comparison of benign and malignant le-sions. Am J Roentgenol 1999; 173: 25-29.
12. Yun M, Kim W, Alnafisi N, et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med 2001; 42:1795-1799.
13. Kumar R, Xiu Y, Yu JQ, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 2004; 45:2058-2062.
14. Tenenbaum F, Groussin L, Foehrenbach H, et al. 18F-fluorodeoxyglucose positron emission tomography as a diag-nostic tool for malignancy of adrenocortical tumors? Preliminary results in 13 consecutive patients. Eur J Endocrinol 2004; 150:789-792.
15. Jana S, Zhang T, Milstein DM, et al. FDG-PET and CT characteriza-tion of adrenal lesions in cancer patients. Eur J Nucl Med Mol Im-aging 2006; 33:29-35.
16. Metser U, Miller E, Lerman H, et al. 18F-FDG PET/CT in the eval-uation of adrenal masses. J Nucl Med 2006; 47:32-37.
17. Chong S, Lee KS, Kim HY, et al. Integrated PET-CT for the charac-terization of adrenal gland lesions in cancer patients: diagnostic ef-ficacy and interpretation pitfalls. Radiographics 2006; 26:1811-1824.
18. Caoili EM, Korobkin M, Brown RK, et al. Differentiating adrenal adenomas from nonadenomas using (18)F-FDG PET/CT: quantita-tive and qualitative evaluation. Acad Radiol 2007; 14:468-475.
19. Han SJ, Kim TS, Jeon SW, et al. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Pract 2007; 61:802-809.
20. Kim HK, Choi YS, Kim K, et al. Preoperative evaluation of adrenal lesions based on imaging studies and laparoscopic adrenalectomy in patients with otherwise operable lung cancer. Lung Cancer 2007; 58:342-347.
21. Vikram R, Yeung HD, Macapinlac HA et al. Utility of PET/CT in differentiating benign from malignant adrenal nodules in patients with cancer. Am J Roentgenol 2008; 191: 1545-1551.
22. Brady MJ, Thomas J, Wong TZ, et al. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. Radiology 2009; 250:523-530.
23. Boland GW, Blake MA, Holalkere NS et al. PET/CT for the charac-terization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Am J Roentgenol 2009; 192:956-962.
24. Boland GW, Dwamena BA, Jagtiani Sangwaiya M, et al. Character-ization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 2011; 259:117-126
25. Shulkin BL, Thompson NW, Shapiro B, et al. Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET. Radi-ology 1999; 212:35-41.
26. Timmers HJ, Chen CC, Carrasquillo JA, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the local-ization of pheochromocytoma and paraganglioma. J Clin Endo-crinol Metab 2009; 94:4757-4767.
27. Leboulleux S, Dromain C, Bonniaud G, et al. Diagnostic and prog-nostic value of 18-fluorodeoxyglucose positron emission tomogra-phy in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab 2006; 91:920-925.
28. Mackie GC, Shulkin BL, Ribeiro RC, et al. Use of [18F]fluorodeoxyglucose positron emission tomography in evalu-ating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab 2006; 91:2665-2671
29. Bergström M, Juhlin C, Bonasera T A, et al. PET-imaging of adrenal cortical tumors with the 11-beta-Hydroxylase tracer 11C-metomidate. J Nucl. Med. 2000; 41:275-82.
30. Groussin L, Bonardel G, Silvera S, et al. 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endo-crinol Metab 2009; 94:1713-1722.
31. Minn H, Salonen A, Friberg J, et al. Imaging of adrenal incidenta-lomas with PET using 11C-metomidate and 18F-FDG. J Nucl Med 2004; 45:972-979.
32. Zettinig G, Mitterhauser M, Wadsak W, et al. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate. Eur J Nucl Med Mol Imaging 2004; 31:1224-1230.
33. Hennings J, Lindhe O, Bergstrom M, et al. [11C]metomidate posi-tron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006; 91:1410-1414.
34. Hennings J, Hellman P, Ahlstrom H, et al. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emis-sion tomography for evaluation of adrenal incidentalomas. Eur J Radiol 2009; 69:314-323.
35. Hennings J, Sundin A, Hagg A, et al. 11C-metomidate positron emission tomography after dexamethasone suppression for detec-tion of small adrenocortical adenomas in primary aldosteronism. Langenbecks Arch Surg 2009; 395:963-967.
36. Razifar P, Hennings J, Monazzam A, et al. Masked volume wise Principal Component Analysis of small adrenocortical tumors in dynamic [11C]-metomidate Positron Emission Tomography. BMC Med Imaging 2009; 9:6.
37. Khan TS, Sundin A, Juhlin C, et al. 11C-metomidate PET imaging of adrenocortical cancer. Eur J Nucl Med Mol Imaging 2003; 30:403-410.